FDA Approves Botox for Migraine
The FDA has now approved Botox (onabotulinumtoxinA) for the treatment of chronic Migraine. Russell Katz, M.D., director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research, stated,
"Chronic migraine is one of the most disabling forms of headache. Patients with chronic migraine experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective treatment options available.
For more information, please see FDA Approves Botox for Migraine.
Get the latest Migraine and headache news, informational articles, tips for living well, and more in my free weekly newsletter. To subscribe, CLICK HERE.